Patricia J. Zondervan

Amsterdam University Medical Centers

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Medical Imaging Medical Imaging professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (3)

Ole Graumann

University of Southern Denmark

DENMARK

View details

María J. Ribal

Head of Uro-Oncology Unit

Hospital Clinic de Barcelona Instituto Clínic de Nefrología y Urología

SPAIN

View details

Tommy Kjærgaard Nielsen

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patricia J. Zondervan

Research Interests

Explore related searches

Contact this professor

Articles (10)

Risk Factors for Residual Unablated Tumour Following CT-Guided Percutaneous Renal Cryoablation: Lessons from the EuRECA Registry

A Closer Look at Radiation Exposure During Percutaneous Cryoablation for T1 Renal Tumors.

Quality Indicators for Renal Cancer Care: A Systematic Review.

Contrast-ultrasound dispersion imaging for renal cell carcinoma diagnostics

A Nationwide Real-world Evaluation of Upfront Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma in the Immunotherapy Era

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort

Gender Demographics in Urology in Europe: Trend Analysis over a 10-year Period.

Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic Review.

A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?

PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients.

Collaborators (3)

Ole Graumann

María J. Ribal

Tommy Kjærgaard Nielsen

Make your next move.